An exploratory study to evaluate the response of salmeterol plus fluticasone propionate vs [versus] fluticasone propionate alone to experimental nasal inoculation with rhinovirus.
Phase of Trial: Phase IV
Latest Information Update: 30 Dec 2016
At a glance
- Drugs Fluticasone propionate; Salmeterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 24 Mar 2009 Actual patient number (16) added as reported by ClinicalTrials.gov.
- 24 Mar 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.